4//SEC Filing
Smith Sean Michael 4
Accession 0001209191-22-015479
CIK 0001404644other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:39 PM ET
Size
5.7 KB
Accession
0001209191-22-015479
Insider Transaction Report
Form 4
Smith Sean Michael
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-02+80,000→ 80,000 totalExercise: $2.72Exp: 2032-03-01→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option will vest on March 2, 2023, and 1/48 of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001914769
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:39 PM ET
- Size
- 5.7 KB